nodes	percent_of_prediction	percent_of_DWPC	metapath
Acetylsalicylic acid—ABCB1—Parkinson's disease	0.379	1	CbGaD
Acetylsalicylic acid—TP53—forelimb—Parkinson's disease	0.0159	0.0697	CbGeAlD
Acetylsalicylic acid—TP53—arm—Parkinson's disease	0.0136	0.0599	CbGeAlD
Acetylsalicylic acid—TP53—manus—Parkinson's disease	0.0121	0.0534	CbGeAlD
Acetylsalicylic acid—TP53—manual digit—Parkinson's disease	0.0119	0.0522	CbGeAlD
Acetylsalicylic acid—NFKBIA—nerve—Parkinson's disease	0.00855	0.0375	CbGeAlD
Acetylsalicylic acid—HSPA5—nerve—Parkinson's disease	0.00837	0.0368	CbGeAlD
Acetylsalicylic acid—TP53—hindbrain—Parkinson's disease	0.00651	0.0286	CbGeAlD
Acetylsalicylic acid—NFKBIA—hindbrain—Parkinson's disease	0.0064	0.0281	CbGeAlD
Acetylsalicylic acid—HSPA5—hindbrain—Parkinson's disease	0.00627	0.0275	CbGeAlD
Acetylsalicylic acid—TP53—embryo—Parkinson's disease	0.00407	0.0179	CbGeAlD
Acetylsalicylic acid—NFKBIA—embryo—Parkinson's disease	0.004	0.0176	CbGeAlD
Acetylsalicylic acid—HSPA5—embryo—Parkinson's disease	0.00392	0.0172	CbGeAlD
Acetylsalicylic acid—TP53—brainstem—Parkinson's disease	0.00373	0.0164	CbGeAlD
Acetylsalicylic acid—NFKBIA—brainstem—Parkinson's disease	0.00367	0.0161	CbGeAlD
Acetylsalicylic acid—TP53—forebrain—Parkinson's disease	0.0036	0.0158	CbGeAlD
Acetylsalicylic acid—HSPA5—brainstem—Parkinson's disease	0.00359	0.0158	CbGeAlD
Acetylsalicylic acid—NFKBIA—forebrain—Parkinson's disease	0.00354	0.0156	CbGeAlD
Acetylsalicylic acid—HSPA5—forebrain—Parkinson's disease	0.00347	0.0152	CbGeAlD
Acetylsalicylic acid—RPS6KA3—embryo—Parkinson's disease	0.00334	0.0147	CbGeAlD
Acetylsalicylic acid—TP53—cardiovascular system—Parkinson's disease	0.00304	0.0134	CbGeAlD
Acetylsalicylic acid—NFKBIA—cardiovascular system—Parkinson's disease	0.00299	0.0131	CbGeAlD
Acetylsalicylic acid—RPS6KA3—forebrain—Parkinson's disease	0.00295	0.013	CbGeAlD
Acetylsalicylic acid—HSPA5—cardiovascular system—Parkinson's disease	0.00293	0.0129	CbGeAlD
Acetylsalicylic acid—NFKBIA—medulla oblongata—Parkinson's disease	0.00256	0.0112	CbGeAlD
Acetylsalicylic acid—HSPA5—medulla oblongata—Parkinson's disease	0.00251	0.011	CbGeAlD
Acetylsalicylic acid—RPS6KA3—cardiovascular system—Parkinson's disease	0.0025	0.011	CbGeAlD
Acetylsalicylic acid—IKBKB—embryo—Parkinson's disease	0.00247	0.0108	CbGeAlD
Acetylsalicylic acid—NFKBIA—midbrain—Parkinson's disease	0.00234	0.0103	CbGeAlD
Acetylsalicylic acid—TP53—spinal cord—Parkinson's disease	0.00232	0.0102	CbGeAlD
Acetylsalicylic acid—HSPA5—midbrain—Parkinson's disease	0.00229	0.0101	CbGeAlD
Acetylsalicylic acid—NFKBIA—spinal cord—Parkinson's disease	0.00228	0.01	CbGeAlD
Acetylsalicylic acid—HSPA5—spinal cord—Parkinson's disease	0.00223	0.00981	CbGeAlD
Acetylsalicylic acid—RPS6KA3—medulla oblongata—Parkinson's disease	0.00213	0.00937	CbGeAlD
Acetylsalicylic acid—TP53—head—Parkinson's disease	0.00206	0.00905	CbGeAlD
Acetylsalicylic acid—NFKBIA—head—Parkinson's disease	0.00203	0.0089	CbGeAlD
Acetylsalicylic acid—HSPA5—head—Parkinson's disease	0.00199	0.00872	CbGeAlD
Acetylsalicylic acid—TP53—nervous system—Parkinson's disease	0.00195	0.00858	CbGeAlD
Acetylsalicylic acid—RPS6KA3—midbrain—Parkinson's disease	0.00195	0.00857	CbGeAlD
Acetylsalicylic acid—NFKBIA—nervous system—Parkinson's disease	0.00192	0.00844	CbGeAlD
Acetylsalicylic acid—RPS6KA3—spinal cord—Parkinson's disease	0.0019	0.00836	CbGeAlD
Acetylsalicylic acid—HSPA5—nervous system—Parkinson's disease	0.00188	0.00827	CbGeAlD
Acetylsalicylic acid—TP53—central nervous system—Parkinson's disease	0.00188	0.00826	CbGeAlD
Acetylsalicylic acid—NFKBIA—central nervous system—Parkinson's disease	0.00185	0.00813	CbGeAlD
Acetylsalicylic acid—IKBKB—cardiovascular system—Parkinson's disease	0.00184	0.0081	CbGeAlD
Acetylsalicylic acid—TP53—cerebellum—Parkinson's disease	0.00184	0.00807	CbGeAlD
Acetylsalicylic acid—HSPA5—central nervous system—Parkinson's disease	0.00181	0.00796	CbGeAlD
Acetylsalicylic acid—NFKBIA—cerebellum—Parkinson's disease	0.00181	0.00794	CbGeAlD
Acetylsalicylic acid—HSPA5—cerebellum—Parkinson's disease	0.00177	0.00778	CbGeAlD
Acetylsalicylic acid—EDNRA—medulla oblongata—Parkinson's disease	0.00173	0.00762	CbGeAlD
Acetylsalicylic acid—RPS6KA3—head—Parkinson's disease	0.00169	0.00743	CbGeAlD
Acetylsalicylic acid—RPS6KA3—nervous system—Parkinson's disease	0.0016	0.00704	CbGeAlD
Acetylsalicylic acid—EDNRA—midbrain—Parkinson's disease	0.00159	0.00696	CbGeAlD
Acetylsalicylic acid—RPS6KA3—central nervous system—Parkinson's disease	0.00154	0.00678	CbGeAlD
Acetylsalicylic acid—RPS6KA3—cerebellum—Parkinson's disease	0.00151	0.00663	CbGeAlD
Acetylsalicylic acid—TP53—brain—Parkinson's disease	0.00149	0.00656	CbGeAlD
Acetylsalicylic acid—NFKBIA—brain—Parkinson's disease	0.00147	0.00645	CbGeAlD
Acetylsalicylic acid—HSPA5—brain—Parkinson's disease	0.00144	0.00632	CbGeAlD
Acetylsalicylic acid—IKBKB—head—Parkinson's disease	0.00125	0.00548	CbGeAlD
Acetylsalicylic acid—RPS6KA3—brain—Parkinson's disease	0.00123	0.00538	CbGeAlD
Acetylsalicylic acid—IKBKB—nervous system—Parkinson's disease	0.00118	0.0052	CbGeAlD
Acetylsalicylic acid—IKBKB—central nervous system—Parkinson's disease	0.00114	0.00501	CbGeAlD
Acetylsalicylic acid—IKBKB—cerebellum—Parkinson's disease	0.00111	0.00489	CbGeAlD
Acetylsalicylic acid—EDNRA—brain—Parkinson's disease	0.000996	0.00438	CbGeAlD
Acetylsalicylic acid—IKBKB—brain—Parkinson's disease	0.000905	0.00397	CbGeAlD
Acetylsalicylic acid—SLC22A7—brain—Parkinson's disease	0.000878	0.00385	CbGeAlD
Acetylsalicylic acid—SLC22A6—brain—Parkinson's disease	0.000847	0.00372	CbGeAlD
Acetylsalicylic acid—PTGS2—embryo—Parkinson's disease	0.000784	0.00344	CbGeAlD
Acetylsalicylic acid—PTGS1—forebrain—Parkinson's disease	0.000725	0.00319	CbGeAlD
Acetylsalicylic acid—PTGS2—forebrain—Parkinson's disease	0.000693	0.00305	CbGeAlD
Acetylsalicylic acid—CYP2C9—cardiovascular system—Parkinson's disease	0.000672	0.00295	CbGeAlD
Acetylsalicylic acid—PTGS1—cardiovascular system—Parkinson's disease	0.000613	0.00269	CbGeAlD
Acetylsalicylic acid—PTGS2—cardiovascular system—Parkinson's disease	0.000586	0.00257	CbGeAlD
Acetylsalicylic acid—ALB—brain—Parkinson's disease	0.000528	0.00232	CbGeAlD
Acetylsalicylic acid—PTGS2—medulla oblongata—Parkinson's disease	0.000501	0.0022	CbGeAlD
Acetylsalicylic acid—ABCB1—embryo—Parkinson's disease	0.000485	0.00213	CbGeAlD
Acetylsalicylic acid—PTGS1—spinal cord—Parkinson's disease	0.000467	0.00205	CbGeAlD
Acetylsalicylic acid—PTGS2—midbrain—Parkinson's disease	0.000458	0.00201	CbGeAlD
Acetylsalicylic acid—PTGS2—spinal cord—Parkinson's disease	0.000447	0.00196	CbGeAlD
Acetylsalicylic acid—ABCB1—forebrain—Parkinson's disease	0.000429	0.00188	CbGeAlD
Acetylsalicylic acid—PTGS1—head—Parkinson's disease	0.000415	0.00182	CbGeAlD
Acetylsalicylic acid—PTGS2—head—Parkinson's disease	0.000397	0.00174	CbGeAlD
Acetylsalicylic acid—PTGS1—nervous system—Parkinson's disease	0.000394	0.00173	CbGeAlD
Acetylsalicylic acid—PTGS1—central nervous system—Parkinson's disease	0.000379	0.00167	CbGeAlD
Acetylsalicylic acid—PTGS2—nervous system—Parkinson's disease	0.000376	0.00165	CbGeAlD
Acetylsalicylic acid—CYP2C8—brain—Parkinson's disease	0.000371	0.00163	CbGeAlD
Acetylsalicylic acid—ABCB1—cardiovascular system—Parkinson's disease	0.000363	0.00159	CbGeAlD
Acetylsalicylic acid—PTGS2—central nervous system—Parkinson's disease	0.000362	0.00159	CbGeAlD
Acetylsalicylic acid—PTGS2—cerebellum—Parkinson's disease	0.000354	0.00156	CbGeAlD
Acetylsalicylic acid—ABCB1—medulla oblongata—Parkinson's disease	0.00031	0.00136	CbGeAlD
Acetylsalicylic acid—PTGS1—brain—Parkinson's disease	0.000301	0.00132	CbGeAlD
Acetylsalicylic acid—PTGS2—brain—Parkinson's disease	0.000288	0.00126	CbGeAlD
Acetylsalicylic acid—ABCB1—midbrain—Parkinson's disease	0.000283	0.00124	CbGeAlD
Acetylsalicylic acid—ABCB1—spinal cord—Parkinson's disease	0.000276	0.00121	CbGeAlD
Acetylsalicylic acid—ABCB1—head—Parkinson's disease	0.000246	0.00108	CbGeAlD
Acetylsalicylic acid—ABCB1—nervous system—Parkinson's disease	0.000233	0.00102	CbGeAlD
Acetylsalicylic acid—ABCB1—central nervous system—Parkinson's disease	0.000224	0.000984	CbGeAlD
Acetylsalicylic acid—ABCB1—cerebellum—Parkinson's disease	0.000219	0.000962	CbGeAlD
Acetylsalicylic acid—ABCB1—brain—Parkinson's disease	0.000178	0.000782	CbGeAlD
Acetylsalicylic acid—RPS6KA3—Developmental Biology—IL6—Parkinson's disease	2.93e-05	7.44e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—APOE—Parkinson's disease	2.92e-05	7.42e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Innate Immune System—IL6—Parkinson's disease	2.89e-05	7.35e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—APOE—Parkinson's disease	2.89e-05	7.33e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Immune System—IL1B—Parkinson's disease	2.88e-05	7.31e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—GCH1—Parkinson's disease	2.88e-05	7.31e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	2.87e-05	7.29e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	2.85e-05	7.23e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—DDC—Parkinson's disease	2.84e-05	7.22e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—FBP1—Parkinson's disease	2.81e-05	7.14e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—DBH—Parkinson's disease	2.81e-05	7.14e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—GBA—Parkinson's disease	2.81e-05	7.14e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—HTR2A—Parkinson's disease	2.81e-05	7.13e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—HTR2A—Parkinson's disease	2.81e-05	7.13e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—RPL23A—Parkinson's disease	2.8e-05	7.12e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—RPL14—Parkinson's disease	2.8e-05	7.12e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—FGF20—Parkinson's disease	2.8e-05	7.11e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—FBP1—Parkinson's disease	2.75e-05	6.97e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—GBA—Parkinson's disease	2.75e-05	6.97e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—DBH—Parkinson's disease	2.75e-05	6.97e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—SOD1—Parkinson's disease	2.74e-05	6.96e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	2.74e-05	6.95e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—ADORA2A—Parkinson's disease	2.72e-05	6.9e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—GSTA4—Parkinson's disease	2.68e-05	6.82e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	2.65e-05	6.73e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Immune System—MAPK8—Parkinson's disease	2.64e-05	6.7e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Transmembrane transport of small molecules—CYCS—Parkinson's disease	2.63e-05	6.68e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—ABL1—Parkinson's disease	2.62e-05	6.64e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—RPS8—Parkinson's disease	2.61e-05	6.64e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—FGF20—Parkinson's disease	2.61e-05	6.64e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—APOE—Parkinson's disease	2.61e-05	6.63e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—APOE—Parkinson's disease	2.61e-05	6.63e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—IGF2—Parkinson's disease	2.6e-05	6.61e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	2.6e-05	6.59e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—ABL1—Parkinson's disease	2.6e-05	6.59e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Innate Immune System—IL6—Parkinson's disease	2.59e-05	6.57e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—IL1B—Parkinson's disease	2.57e-05	6.54e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—FBP1—Parkinson's disease	2.56e-05	6.51e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—GBA—Parkinson's disease	2.56e-05	6.51e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—DBH—Parkinson's disease	2.56e-05	6.51e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—Parkinson's disease	2.52e-05	6.41e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—INSR—Parkinson's disease	2.51e-05	6.37e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—INS—Parkinson's disease	2.49e-05	6.33e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—INS—Parkinson's disease	2.47e-05	6.26e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—HGF—Parkinson's disease	2.46e-05	6.25e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—Parkinson's disease	2.46e-05	6.24e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—HGF—Parkinson's disease	2.44e-05	6.2e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—PLA2G6—Parkinson's disease	2.42e-05	6.14e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	2.4e-05	6.09e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—MAOB—Parkinson's disease	2.39e-05	6.08e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—FGB—Parkinson's disease	2.37e-05	6.02e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—MAPK8—Parkinson's disease	2.36e-05	5.99e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—HTR1A—Parkinson's disease	2.36e-05	5.99e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—TAC1—Parkinson's disease	2.32e-05	5.89e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—CASP3—Parkinson's disease	2.32e-05	5.89e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—DDC—Parkinson's disease	2.31e-05	5.87e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Transmembrane transport of small molecules—CYCS—Parkinson's disease	2.3e-05	5.85e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—DDC—Parkinson's disease	2.3e-05	5.84e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Cytokine Signaling in Immune system—IL6—Parkinson's disease	2.29e-05	5.83e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	2.29e-05	5.8e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	2.28e-05	5.78e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—DRD1—Parkinson's disease	2.28e-05	5.78e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—Parkinson's disease	2.26e-05	5.74e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling by NGF—IL6—Parkinson's disease	2.26e-05	5.73e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—CYP2D6—Parkinson's disease	2.24e-05	5.69e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—INS—Parkinson's disease	2.23e-05	5.66e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—INS—Parkinson's disease	2.23e-05	5.66e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—DRD3—Parkinson's disease	2.2e-05	5.6e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—CTGF—Parkinson's disease	2.2e-05	5.58e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	2.19e-05	5.57e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—GSTA4—Parkinson's disease	2.18e-05	5.55e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—GSTA4—Parkinson's disease	2.17e-05	5.52e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	2.16e-05	5.48e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	2.14e-05	5.45e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—MAPK8—Parkinson's disease	2.13e-05	5.41e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—DDC—Parkinson's disease	2.06e-05	5.24e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—ADRBK1—Parkinson's disease	2.06e-05	5.23e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—CYP2E1—Parkinson's disease	2.05e-05	5.2e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—NQO1—Parkinson's disease	2.03e-05	5.14e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Innate Immune System—MAPK8—Parkinson's disease	2.02e-05	5.12e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—DDC—Parkinson's disease	2.02e-05	5.12e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	2e-05	5.08e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—TH—Parkinson's disease	2e-05	5.07e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—DRD2—Parkinson's disease	1.99e-05	5.06e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—HTR7—Parkinson's disease	1.99e-05	5.06e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—PLA2G6—Parkinson's disease	1.97e-05	4.99e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—PLA2G6—Parkinson's disease	1.96e-05	4.97e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—GSTA4—Parkinson's disease	1.95e-05	4.95e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—MAOB—Parkinson's disease	1.95e-05	4.94e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Disease—IL6—Parkinson's disease	1.94e-05	4.94e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—MAOB—Parkinson's disease	1.94e-05	4.92e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	1.93e-05	4.89e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—ADRBK1—Parkinson's disease	1.92e-05	4.88e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—CYCS—Parkinson's disease	1.92e-05	4.87e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—HSPA1A—Parkinson's disease	1.91e-05	4.84e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—GSTA4—Parkinson's disease	1.9e-05	4.83e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—DDC—Parkinson's disease	1.88e-05	4.78e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—CASP3—Parkinson's disease	1.86e-05	4.72e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	1.85e-05	4.71e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	1.84e-05	4.68e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—CASP3—Parkinson's disease	1.84e-05	4.66e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Parkinson's disease	1.79e-05	4.54e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—CYP2D6—Parkinson's disease	1.78e-05	4.52e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—GSTA4—Parkinson's disease	1.78e-05	4.51e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—PLA2G6—Parkinson's disease	1.76e-05	4.46e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	1.76e-05	4.46e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—CTGF—Parkinson's disease	1.75e-05	4.43e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—MAOB—Parkinson's disease	1.74e-05	4.41e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—PLA2G6—Parkinson's disease	1.71e-05	4.35e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—MAPK8—Parkinson's disease	1.71e-05	4.33e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—COMT—Parkinson's disease	1.7e-05	4.31e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—MAOB—Parkinson's disease	1.7e-05	4.31e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—GSTP1—Parkinson's disease	1.69e-05	4.29e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—MAPK8—Parkinson's disease	1.69e-05	4.28e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Immune System—IL6—Parkinson's disease	1.69e-05	4.28e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—MAOA—Parkinson's disease	1.69e-05	4.28e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—IGF2—Parkinson's disease	1.67e-05	4.24e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—HMOX1—Parkinson's disease	1.67e-05	4.23e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—CASP3—Parkinson's disease	1.66e-05	4.22e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—CASP3—Parkinson's disease	1.66e-05	4.22e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	1.65e-05	4.2e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling by GPCR—IL6—Parkinson's disease	1.65e-05	4.19e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling by GPCR—IL6—Parkinson's disease	1.65e-05	4.19e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—CYP2E1—Parkinson's disease	1.63e-05	4.13e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—IGF1R—Parkinson's disease	1.62e-05	4.1e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—NQO1—Parkinson's disease	1.61e-05	4.08e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—PLA2G6—Parkinson's disease	1.6e-05	4.07e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—ABCB1—Parkinson's disease	1.6e-05	4.06e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—EDN1—Parkinson's disease	1.6e-05	4.05e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—TH—Parkinson's disease	1.59e-05	4.03e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—MAOB—Parkinson's disease	1.58e-05	4.02e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—GSTM1—Parkinson's disease	1.55e-05	3.94e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—MAPK8—Parkinson's disease	1.53e-05	3.88e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—MAPK8—Parkinson's disease	1.53e-05	3.88e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—CYCS—Parkinson's disease	1.52e-05	3.86e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	1.51e-05	3.83e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—IL6—Parkinson's disease	1.51e-05	3.83e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—GPX1—Parkinson's disease	1.49e-05	3.78e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—NGF—Parkinson's disease	1.47e-05	3.73e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—CYP2D6—Parkinson's disease	1.45e-05	3.67e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—CYP2D6—Parkinson's disease	1.44e-05	3.65e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—CTGF—Parkinson's disease	1.42e-05	3.61e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—CTGF—Parkinson's disease	1.41e-05	3.59e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—HTR2A—Parkinson's disease	1.4e-05	3.55e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—MTHFR—Parkinson's disease	1.37e-05	3.48e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—IL6—Parkinson's disease	1.36e-05	3.46e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—COMT—Parkinson's disease	1.35e-05	3.42e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—GSTP1—Parkinson's disease	1.34e-05	3.41e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—MAOA—Parkinson's disease	1.34e-05	3.4e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—CYP2E1—Parkinson's disease	1.32e-05	3.36e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—HMOX1—Parkinson's disease	1.32e-05	3.36e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—CYP2E1—Parkinson's disease	1.32e-05	3.34e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—NQO1—Parkinson's disease	1.31e-05	3.32e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—NQO1—Parkinson's disease	1.3e-05	3.3e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—MTHFR—Parkinson's disease	1.3e-05	3.3e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—APOE—Parkinson's disease	1.3e-05	3.3e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—CYP2D6—Parkinson's disease	1.29e-05	3.28e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—TH—Parkinson's disease	1.29e-05	3.28e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Innate Immune System—IL6—Parkinson's disease	1.29e-05	3.27e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—TH—Parkinson's disease	1.28e-05	3.26e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—IL1B—Parkinson's disease	1.28e-05	3.25e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—APOE—Parkinson's disease	1.28e-05	3.24e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—ABCB1—Parkinson's disease	1.27e-05	3.22e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—CTGF—Parkinson's disease	1.27e-05	3.22e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—CYP2D6—Parkinson's disease	1.26e-05	3.2e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—CYCS—Parkinson's disease	1.24e-05	3.14e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—CTGF—Parkinson's disease	1.24e-05	3.14e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—GSTM1—Parkinson's disease	1.23e-05	3.13e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—CYCS—Parkinson's disease	1.23e-05	3.13e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—APOE—Parkinson's disease	1.21e-05	3.08e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—CYP2E1—Parkinson's disease	1.18e-05	3e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—GPX1—Parkinson's disease	1.18e-05	3e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—CYP2D6—Parkinson's disease	1.18e-05	2.99e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—MAPK8—Parkinson's disease	1.17e-05	2.98e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—NQO1—Parkinson's disease	1.17e-05	2.97e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—CTGF—Parkinson's disease	1.16e-05	2.94e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—CYP2E1—Parkinson's disease	1.15e-05	2.93e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—TH—Parkinson's disease	1.15e-05	2.92e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—NQO1—Parkinson's disease	1.14e-05	2.9e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—TH—Parkinson's disease	1.12e-05	2.85e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—INS—Parkinson's disease	1.11e-05	2.82e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—CYCS—Parkinson's disease	1.11e-05	2.81e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—COMT—Parkinson's disease	1.1e-05	2.78e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—GSTP1—Parkinson's disease	1.09e-05	2.77e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—INS—Parkinson's disease	1.09e-05	2.77e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—COMT—Parkinson's disease	1.09e-05	2.77e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—IL6—Parkinson's disease	1.09e-05	2.77e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—MTHFR—Parkinson's disease	1.09e-05	2.77e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—MAOA—Parkinson's disease	1.09e-05	2.77e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—GSTP1—Parkinson's disease	1.09e-05	2.76e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—MAOA—Parkinson's disease	1.08e-05	2.75e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—CYCS—Parkinson's disease	1.08e-05	2.74e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—IL6—Parkinson's disease	1.08e-05	2.74e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—CYP2E1—Parkinson's disease	1.08e-05	2.74e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—HMOX1—Parkinson's disease	1.08e-05	2.73e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—HMOX1—Parkinson's disease	1.07e-05	2.72e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—NQO1—Parkinson's disease	1.07e-05	2.7e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—TH—Parkinson's disease	1.05e-05	2.67e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—INS—Parkinson's disease	1.03e-05	2.63e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—ABCB1—Parkinson's disease	1.03e-05	2.62e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—ABCB1—Parkinson's disease	1.03e-05	2.61e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—APOE—Parkinson's disease	1.01e-05	2.58e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—CYCS—Parkinson's disease	1.01e-05	2.56e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—GSTM1—Parkinson's disease	1e-05	2.55e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—GSTM1—Parkinson's disease	9.97e-06	2.53e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—COMT—Parkinson's disease	9.79e-06	2.49e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—IL6—Parkinson's disease	9.74e-06	2.47e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—IL6—Parkinson's disease	9.74e-06	2.47e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—GSTP1—Parkinson's disease	9.74e-06	2.47e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—MAOA—Parkinson's disease	9.72e-06	2.47e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—HMOX1—Parkinson's disease	9.61e-06	2.44e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—GPX1—Parkinson's disease	9.6e-06	2.44e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—COMT—Parkinson's disease	9.55e-06	2.43e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—GPX1—Parkinson's disease	9.55e-06	2.43e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—GSTP1—Parkinson's disease	9.51e-06	2.41e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—MAOA—Parkinson's disease	9.49e-06	2.41e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—HMOX1—Parkinson's disease	9.38e-06	2.38e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—ABCB1—Parkinson's disease	9.22e-06	2.34e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—GSTM1—Parkinson's disease	8.95e-06	2.27e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—COMT—Parkinson's disease	8.92e-06	2.27e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—GSTP1—Parkinson's disease	8.88e-06	2.26e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—MTHFR—Parkinson's disease	8.86e-06	2.25e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—MAOA—Parkinson's disease	8.86e-06	2.25e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—MTHFR—Parkinson's disease	8.81e-06	2.24e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—HMOX1—Parkinson's disease	8.76e-06	2.22e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—GSTM1—Parkinson's disease	8.74e-06	2.22e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—INS—Parkinson's disease	8.66e-06	2.2e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—GPX1—Parkinson's disease	8.57e-06	2.18e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—ABCB1—Parkinson's disease	8.41e-06	2.14e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—GPX1—Parkinson's disease	8.37e-06	2.13e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—CASP3—Parkinson's disease	8.26e-06	2.1e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—APOE—Parkinson's disease	8.25e-06	2.1e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—APOE—Parkinson's disease	8.21e-06	2.08e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—GSTM1—Parkinson's disease	8.16e-06	2.07e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—MTHFR—Parkinson's disease	7.91e-06	2.01e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—GPX1—Parkinson's disease	7.82e-06	1.99e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—MTHFR—Parkinson's disease	7.72e-06	1.96e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—MAPK8—Parkinson's disease	7.59e-06	1.93e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—IL6—Parkinson's disease	7.5e-06	1.9e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—APOE—Parkinson's disease	7.37e-06	1.87e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—MTHFR—Parkinson's disease	7.21e-06	1.83e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—APOE—Parkinson's disease	7.19e-06	1.83e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—INS—Parkinson's disease	7.05e-06	1.79e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—INS—Parkinson's disease	7.01e-06	1.78e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—APOE—Parkinson's disease	6.72e-06	1.71e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—INS—Parkinson's disease	6.29e-06	1.6e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—INS—Parkinson's disease	6.14e-06	1.56e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—INS—Parkinson's disease	5.74e-06	1.46e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—IL6—Parkinson's disease	4.85e-06	1.23e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—IL6—Parkinson's disease	4.52e-06	1.15e-05	CbGpPWpGaD
